Fenofibrate Caplets and Capsules

Fenofibrate Caplets and Capsules

Form: Caplets and Capsules

Strength: 67 mg, 135 mg, 160 mg, and 145 mg

Reference Brands: Tricor(US), Fenogal, Lipanor(EU)

Category: Heart Disorder

Fenofibrate caplets and capsules, marketed as Tricor in the US and as Fenogal or Lipanor in the EU, are approved for managing hypertriglyceridemia and hypercholesterolemia. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical trial and quality information, while the EU’s EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring regional regulatory adherence supports timely approval, safe use, and worldwide availability of fenofibrate capsules, promoting cardiovascular health and lipid management globally.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Aliskiren tablets

Strength: 150 mg, 300 mg

Form: Tablets

Reference Brands: Tekturna(US & EU)

View Details Get Enquiry
Atenolol tablets

Strength: 25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: Tenormin(US)

View Details Get Enquiry
Metoprolol Tartrate tablet

Strength: IR: 25 mg, 50 mg, 100 mg; ER: 25 mg, 50 mg, 100 mg, 200 mg

Form: Tablets(IR & ER)

Reference Brands: US: Lopressor(IR); Toprol-XL(ER)

View Details Get Enquiry
Nifedipine tablets(IR/ER)

Strength: 10 mg, 20 mg, 30 mg, 60 mg, 90 mg (IR and ER forms)

Form: Tablet(IR & ER)

Reference Brands: Procardia(US);

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.